The technology has been developed by Bionic Vision Australia, a research consortium of five academic institutes which has received $50m of Australian Federal Government funding over a 5 year period and together with in-kind contribution by the institutes has had funding of over $100m. Among the large multidisciplinary team of researchers are a number of pioneers of the original Cochlear technology. BVT, which holds the licenses to the patents surrounding the technology, will now progress the technology to commercialisation.
Our product pipeline consists of two generations of devices which aim to increase mobility and independence of patients and enables increasing visual acuity.
BVT aims to be the world leader in the development and production of suprachoroidally positioned retinal prosthesis for restoring vision to the blind and slowing the progression of retinal degeneration.